Anaphylactic Shock Due to Technetium (99mTc)Tetrofosmin During Myocardial Perfusion Scintigraphy: A Case Report

被引：0
|
作者：
Hashimoto, Sho [1 ]
Tanaka, Tetsuya [1 ]
Shimoda, Yoshiaki [1 ]
Tanaka, Mariko [1 ]
Kondo, Morihiko [1 ]
机构：
[1] Kobe Cent Hosp, JCHO, Cardiol, Kobe, Hyogo, Japan
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2024年 / 16卷 / 01期
关键词：
allergic reaction; technetium tc-99m; myocardial scintigraphy; stable ischemic heart disease; anaphylactic shock; NUCLEAR-MEDICINE; ADVERSE-REACTIONS;
D O I：
10.7759/cureus.52644
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Myocardial perfusion scintigraphy is a popular minimally invasive method for evaluating chronic coronary disease (CCD). We performed myocardial scintigraphy to assess CCD in a 74 -year -old man with a history of allergy to contrast media. The patient developed anaphylactic shock immediately after the administration of the technetium (99mTc)-tetrofosmin preparation. This is the first report of anaphylactic shock due to 99mTc- tetrofosmin administration during myocardial perfusion scintigraphy.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Efficiency comparison between 99mTc tetrofosmin and 99mTc sestamibi myocardial perfusion studies.
    Borges-Neto, S
    Hanson, MW
    Ravizzini, GC
    Wong, TZ
    Hagge, RJ
    Shaw, LK
    Coleman, RE
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 160P - 160P
  • [2] Evaluation of cardiovascular complications with 99mTc tetrofosmin gated myocardial perfusion scintigraphy in patients with thalassernia major
    Gedik, G. K.
    Caglar, M.
    Unal, S.
    Gumruk, F.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2008, 27 (03): : 191 - 198
  • [3] Pharmaceutical interviews to overcome digestive artefacts on [99mTc]Tc-tetrofosmin myocardial perfusion scintigraphy
    Nail, Vincent
    Moyon, Anais
    Nachar, Oriane
    Gabriel, Sophie
    Guillet, Benjamin
    Garrigue, Philippe
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (05) : 1480 - 1483
  • [4] Comparison between pulmonary tuberculosis scintigraphy with 99mTc MIBI and 99mTc Tetrofosmin
    Stefanescu, C.
    Rusu, V.
    Boisteanu, D.
    Oleniuc, M.
    Hurjui, D.
    Costin, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S230 - S230
  • [5] Cost analysis comparison between 99mTc tetrofosmin and 99mTc sestamibi myocardial perfusion imaging protocols
    Ravizzini, G
    Pagnanelli, RA
    Coleman, RE
    Borges-Neto, S
    RADIOLOGY, 2001, 221 : 612 - 612
  • [6] 99mTc tetrofosmin myocardial perfusion scintigraphy in CAD Performance with early and standard delayed acquisition and fractional flow reserve
    Pirich, C.
    Keinrath, P.
    Rettenbacher, L.
    Rendl, G.
    Holzmannhofer, J.
    Hammerer, M.
    Schuler, J.
    Beheshti, M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2014, 53 (03): : 111 - 116
  • [7] Macrosalb-(99mtc)Anaphylactic reaction: case report
    Reactions Weekly, 2019, 1748 (1) : 311 - 311
  • [8] 99mTc sestamibi and 99mTc tetrofosmin scintigraphy for predicting resistance to chemotherapy:: a critical review of clinical data
    Van de Wiele, C
    Rottey, S
    Goethals, I
    Buscombe, J
    Van Belle, S
    De Vos, F
    Dierckx, RA
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (09) : 945 - 950
  • [9] 99mTc sestamibi myocardial perfusion scintigraphy with the novel use of metamizol for the detection of perfusion reversibility
    Ergun, Eser Lay
    Caglar, Meltem
    Bozkurt, Murat Fani
    Ergun, Hakan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (08) : 1530 - 1536
  • [10] The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences
    Spanu, A
    Farris, A
    Schillaci, O
    Chessa, F
    Solinas, ME
    Falchi, A
    Madeddu, G
    Nuvoli, S
    Madeddu, G
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (02) : 145 - 154
12345